SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-072800
Filing Date
2024-03-20
Accepted
2024-03-20 16:57:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d798705ds3.htm S-3 277106
2 EX-4.5 d798705dex45.htm EX-4.5 293118
3 EX-5.1 d798705dex51.htm EX-5.1 23836
4 EX-23.1 d798705dex231.htm EX-23.1 2232
5 EX-FILING FEES d798705dexfilingfees.htm EX-FILING FEES 51748
6 GRAPHIC g798705g01a03.jpg GRAPHIC 32739
7 GRAPHIC g798705g07f46.jpg GRAPHIC 6236
8 GRAPHIC g798705g28f97.jpg GRAPHIC 5010
  Complete submission text file 0001193125-24-072800.txt   710076
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278110 | Film No.: 24768428
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)